Astellas Pharma Inc.
[WKN: 856273 | ISIN: JP3942400007]
Aktienkurse
8,782€ 1,22%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid: Ask:

Echtzeit-Chart der Astellas Pharma Inc. Aktie

Astellas Pharma Inc. Chart

Charttool öffnen

Börsenkurse Astellas Pharma Inc.

Börse Stuttgart - - - - 8,782€ 5,60%
Börse Frankfurt - - - - 8,797€ 4,70%
gettex - - - - 8,753€ 1,58%
Tradegate - - - - 8,726€ -0,29%
Lang & Schwarz - - - - 8,808€ 2,00%
Echtzeit Euro - - - - 8,782€ 1,22%

Profil der Astellas Pharma Inc. Aktie

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.